Inhibition of Angiotensin-Converting Enzyme in Congestive Heart Failure

Harry Feld, Mark A. Greenberg, Marvin E. Jaffe, Robert A. Hamilton, Milton Packer, Wai Hung Lee

Research output: Contribution to journalLetter

4 Scopus citations

Abstract

To the Editor: The recent study by Packer et al. (Oct. 2 issue),1 comparing the effects of enalapril and captopril in heart failure, has problems with study design that make the implications of the study less broad than the investigators intended. The dosages of the inhibitors of angiotensin-converting enzyme (150 mg of captopril per day and 40 mg of enalapril per day) are larger than those currently used by most clinicians. Captopril was originally investigated in doses of up to 150 mg three times a day. However, the tendency over recent years has been to use this drug in doses…

Original languageEnglish (US)
Pages (from-to)879-880
Number of pages2
JournalNew England Journal of Medicine
Volume316
Issue number14
DOIs
StatePublished - Apr 2 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Inhibition of Angiotensin-Converting Enzyme in Congestive Heart Failure'. Together they form a unique fingerprint.

Cite this